Conferences
ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
BSH 2015
20 - 22 Apr 2015
The EICC, Edinburgh, United Kingdom of Great Britain and Northern Ireland
The meeting will be held in Edinburgh the inspiring capital of Scotland, where centuries of history meet a vibrant, cosmopolitan city in an unforgettable setting.
The Annual Scientific Meeting remains a critical core component of the BSH Society. Today the work of the Society is more relevant than ever - both in the laboratory and clinical setting. Our annual meeting is an important gathering of our haematology community and an outstanding opportunity to network with multidisciplinary colleagues. The meeting provides us with guidance on changing clinical and laboratory practice and a comprehensive update on advances in haematology. Improving outcomes is the theme that I have chosen for this year’s meeting. We improve outcomes for our patients through expert application of advances in diagnostics and therapeutics. The vision of our Society is to transform patient care through excellence in haematology. To be excellent we must be expert and the annual meeting is one of the ways our Society helps us to maintain our expertise.
Virtual learning environment as a tool to provide laboratory training for hemato...
Dr Nita Prasannan - Guy's Hospital, London, UK
Analysis of iron status in paediatric acute lymphoblastic leukaemia
Dr Charlotte Brierley - Royal Hospital for Sick Children, Edinburgh, UK
New approaches to diffuse large B-cell lymphoma
Dr Andrew Davies - University Hospital Southampton NHS Foundation Trust, Southam...
Latest in novel approaches to CLL and MCL
Professor Peter Hillmen - Leeds Teaching Hospitals NHS Trust, Leeds, UK
Positive results in phase II study of copanlisib treating NHL and CLL
Dr George Follows - Cambridge University Hospitals NHS Foundation Trust, Cambrid...
Dual mTOR inhibition effective in reducing tumour load in CLL
Dr Emilio Cosimo - University of Glasgow, Glasgow, UK
Putting the patient at the centre of cancer-associated thrombosis treatment deci...
Dr Simon Noble - Cardiff University, Cardiff, UK
Developing treatments for indolent non hodgkin lymphoma
Dr Andrew Davies and Dr Paul Fields
Latest trials and outcomes with new CLL treatments
Dr George Follows and Professor Peter Hillmen
Updated results on phase III CLL trial shows 90% response rate using ibrutinib
Dr Claire Dearden - Royal Marsden Hospital, London, UK